Latest News in the pharma Industry

Research & Development

FDA approves Genentech’s Actemra for giant cell arteritis

FDA approves Genentech’s Actemra for giant cell arteritis

22 May 2017

Sixth FDA approval for Actemra since its US launch in 2010,

Read more 
Catalent and Therachon to advance clinical development of innovative protein therapy for achondroplasia

Catalent and Therachon to advance clinical development of innovative protein therapy for achondroplasia

15 May 2017

Catalent Biologics will use its proprietary GPEx technology to produce different protein variants for Therachon,

Read more 
Positive results for Lilly's three Phase III studies of galcanezumab for the prevention of migraine

Positive results for Lilly's three Phase III studies of galcanezumab for the prevention of migraine

14 May 2017

Read more 
Genentech to present new data on personalized medicines and cancer immunotherapies

Genentech to present new data on personalized medicines and cancer immunotherapies

12 May 2017

New pivotal results for Perjeta and Alecensa demonstrating improvement over standards of care.

Read more 
Avastin as effective as Eylea for treating central retinal vein occlusion

Avastin as effective as Eylea for treating central retinal vein occlusion

12 May 2017

NIH-funded clinical trial shows use of either drug improved vision and had few side effects.

Read more 
Merck's Keytruda scores another FDA approval

Merck's Keytruda scores another FDA approval

11 May 2017

FDA approves Keytruda as first-line combination therapy with pemetrexed and carboplatin for patients with metastatic nonsquamous non-small cell lung cancer (NSCLC) irrespective of PD-L1 expression.

Read more 
Roche's Tecentriq flops during Phase III trial

Roche's Tecentriq flops during Phase III trial

10 May 2017

IMvigor211 failed to meet its primary endpoint of overall survival (OS) compared with chemotherapy.

Read more 
Optibrium and Goldfinch Bio sign agreement for StarDrop license

Optibrium and Goldfinch Bio sign agreement for StarDrop license

9 May 2017

Goldfinch Bio’s researchers select StarDrop to guide successful drug discovery.

Read more 
New buprenorphine wafers could help thousands battling opioid addiction

New buprenorphine wafers could help thousands battling opioid addiction

8 May 2017

When compared with current hard sublingual tablets, the novel formulation dissolved quickly with no increased safety concerns and no demonstrable difference in efficacy.

Read more 
SGS Clinical Research announces results of FiH studies using novel virus as experimental challenge agent

SGS Clinical Research announces results of FiH studies using novel virus as experimental challenge agent

4 May 2017

Strain represents one of the common current circulating strains of influenza of a pandemic origin.

Read more 
NIH discovery in mice could lead to new class of medications to fight mid-life obesity

NIH discovery in mice could lead to new class of medications to fight mid-life obesity

3 May 2017

With lower rates of obesity, the researchers say rates of heart disease, diabetes, and other diseases that tend to increase with age, including cancer and Alzheimer’s disease, could fall as well.

Read more 
Isogenica introduces next-generation, fully synthetic human Fab antibody fragment library

Isogenica introduces next-generation, fully synthetic human Fab antibody fragment library

3 May 2017

Library claimed to offer "the most efficient route to therapeutic antibody lead identification".

Read more